RYONCIL
STN: 125706
Proper Name: remestemcel-L-rknd
Tradename: RYONCIL
Manufacturer: Mesoblast, Inc.
Indication:
- Indicated for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months of age and older.
Product Information
- Package Insert - RYONCIL
- Demographic Subgroup Information – remestemcel-L-rknd (RYONCIL)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.